Inside Therapeutics

Angoulême, France

Inside Therapeutics offers microfluidic-based systems for nanoparticle manufacturing, focusing on LNP-RNA vaccine development and oncology.

$1.4M raised

Jun 2024

Seed

Analytics Biopharma Biotechnology Test and Measurement

Top Investors

Newfund Skalepark

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Inside Therapeutics

How much funding has Inside Therapeutics raised?

Inside Therapeutics has raised $1.4M in total funding. The most recent round was Seed. The last funding was announced in June 2024.

Who are Inside Therapeutics's investors?

Inside Therapeutics's investors include Newfund, Skalepark.

Where is Inside Therapeutics headquartered?

Inside Therapeutics is headquartered in Angoulême, France.

What does Inside Therapeutics do?

Inside Therapeutics offers microfluidic-based systems for nanoparticle manufacturing, focusing on LNP-RNA vaccine development and oncology.

What stage is Inside Therapeutics at?

Inside Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 20, 2024.

MLA

"Inside Therapeutics — Funding & Investors." VCBacked, June 20, 2024, https://www.vcbacked.co/company/inside-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2024). Inside Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/inside-therapeutics

Wikipedia (cite web)

{{cite web |title=Inside Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/inside-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 20, 2024.

Similar Companies in Analytics